Skip to main content
Equibles

RENAISSANCE TECHNOLOGIES LLC

Position in IMVT — Immunovant, Inc.

CIK 1037389 NEW YORK, NY
Back to IMVT Full portfolio

Position in IMVT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$28,003,604
+$23,221,904 QoQ
Shares Held
726,800
+277.6% QoQ
Ownership
0.352%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#28
of 226 holders
Holding Since
Jun 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. IMVT ranks #26 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EXEL
Exelixis, Inc.
 13,427,993 $730,617,099
2 CORT
Corcept Therapeutics Inc
 5,261,628 $457,498,554
3 INCY
Incyte Corp
 3,512,132 $398,135,283
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 320,008 $158,957,573
5 JAZZ
Jazz Pharmaceuticals plc
 562,073 $135,442,730
6 RPRX
Royalty Pharma plc
 1,935,800 $108,540,306
7 TVTX
Travere Therapeutics, Inc.
 1,833,079 $104,137,217
8 GMAB
Genmab A/S
 3,517,850 $96,635,339

All Filings in IMVT

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $28,003,604 726,800
2026-03-31 $4,781,700 192,500
2025-06-30 $3,862,400 241,400
2025-03-31 $6,765,931 395,900
2024-12-31 $2,003,893 80,900
2024-09-30 $5,388,390 189,000
2024-06-30 $10,245,840 388,100
2024-03-31 $10,975,707 339,700
2023-12-31 $770,979 18,300
2023-09-30 $8,499,546 221,400
2023-06-30 $8,874,166 467,800
2023-03-31 $7,632,657 492,112
2022-12-31 $6,107,775 344,100
2022-09-30 $1,966,950 352,500
2022-06-30 $1,297,140 332,600
2022-03-31 $554,857 100,700
2021-12-31 $149,952 17,600
2020-12-31 $258,664 5,600
2020-06-30 $883,905 36,300